Author
Stephen Page
Writer on DMT, ayahuasca, iboga and tryptamine research. LLB; incoming MSc in Psychedelics: Mind, Medicine and Culture, University of Exeter (2026)
Ethics
The Room and the Record
There is a claim in psychedelic research that has been repeated for sixty years without being tied convincingly to a lasting biological measurement. It goes like this: the drug is not the whole story.
ARDMT Field Notes
Can a therapist guide you somewhere they've never been?
The medicine opens the door. Whether the person sitting beside you can actually help you walk through it — and how you'd even know — is the question the field hasn't reckoned with yet.
Understanding
The Instrument and the Threshold
This essay is about a narrow and unglamorous claim: that the field's standard method for answering the question cannot answer it. Not that the answer is one thing or the other.
Cabinet of Marginalia
The Litany Against Fear
In March of 2026, Christian Angermayer — biotech financier, founder and chairman of the psychedelic pharma company AtaiBeckley, largest shareholder in the same — published a short essay with a large claim.
ARDMT Field Notes
Be Careful Not to Colonise Hyperspace
The phrase surfaces, briefly, on a slide. Be careful not to colonise hyperspace. It is meant, I think, as a caution about attitude — about arriving in the DMT state with the postures of the conqueror rather than the
Foundations
Holding the Door Open
DMT is not exotic in the sense of being rare. It is one of the most widely distributed psychedelics in nature, produced by a great many plants and animals — and, importantly, by mammals, including, in trace amounts, us. (We will come back to that startling fact in Part VII.)
Cabinet of Marginalia
The Trained Bystander Paradox
Should Voluntarily-Acquired Rescue Capability Generate a Limited Positive Duty in English Negligence Law?
ARDMT Field Notes
The Toadstool Everyone Knows
Fly agaric is the most recognisable mushroom on Earth — Santa's colours, Alice's mushroom, Mario's power-up, the sacrament of the Vedas. Strip away the stories that aren't true and what remains is stranger than any of them:
ARDMT Field Notes
The Net That Holds the Brake: How One Dose of Psilocybin Quiets the Brain's Drive Toward Reward
A single injection, two days of silence, and then a measurable change in how much rats wanted what they used to want most — traced down to one inhibitory cell type wrapped in structural netting in the prefrontal cortex.
ARDMT Field Notes
Who Owns a Molecule That Has Never Existed in Nature?
In April 2026, a team at the Weizmann Institute of Science announced they had engineered a single, unglamorous relative of tobacco to produce five different natural psychedelics at once: psilocybin and psilocin, the mushroom compounds; DMT,
Cabinet of Marginalia
The Habit of the Universe
On morphic resonance, decapitated worms, lions that remember Rome, and what we might be doing when we take psychedelics
ICPR 2026
Notes from Haarlem
The question now is harder, and more interesting: how, exactly, are they to be used? What role does the subjective experience play? Are the non-hallucinogenic alternatives now in development the future of the field or a category error?